Attend PCa 'College': Active Surveillance 101 course launches at ASPI meeting on Sept. 24
Get your Prostate cancer 'diploma'
By Howard Wolinsky
ASPI (Active Surveillance Patients International) will be premiering the first of a new video series titled “Active Surveillance 101" at noon Eastern on September 24, 2022.
Register here: ASPI SEPTEMBER ZOOM MEETING
Like 101-level courses in colleges, AS 101 is aimed at teaching the basics. In this case, it's the basics of active surveillance, close monitoring of low- to favorable intermediate-risk prostate cancer.
The program features conversations between actual patients and their partners/spouses and leading experts. The goal of this series is to reach all AS candidates, including those who have not yet been diagnosed with prostate cancer but have rising PSAs (prostate-specific antigen) blood levels and offer them an introduction to AS and help them formulate questions when they go to their family doctors, urologists, or oncologists.
The first episode features a couple, Nancy and Larry White in a simulated office visit with Dr. Steve Spann, a top family physician and dean of the University of Houston College of Medicine. They discuss Larry's rising PSA and what it may mean.
In subsequent episodes, the couple visits Dr. Laurence Klotz, of the University of Toronto, the "father of active surveillance." Other episodes of AS 101 are being developed on biopsies, imaging, and DNA testing.
AS 101 is sponsored by the Active Surveillance Coalition, which includes Active Surveillance Patients International, the AnCan Virtual Support Group for Active Surveillance, Prostate Cancer Support Canada, Prostate Cancer Research Institute, and TheActiveSurveillor.com newsletter. We encourage you to share this series with anyone who you know who is dealing with this issue, including your family physician.
Last call for AnCan debate tonight on prostate biopsies
AnCan’s Virtual Support Group for Patients on Active Surveillance is holding a program, “Prostate Cancer Biopsies...The Great Debate,” on transrectal biopsies vs. transperineal biopsies.
The program will be 8-9:30 p.m. Eastern on August 29. Register here: https://bit.ly/3OJ9Mmu
Deborah Kaye, MD, Assistant Professor Duke UniversityDivision of Urology and Duke Clinical Research Institute Margolis Policy Center, will argue for transrectal biopsies. Arvin George, MD, a urologic surgeon specializing in the diagnosis and management of genitourinary cancers at the University of Michigan Health, will argue for transperineal procedures.
Co-sponsors include ASPI, Prostate Cancer Support Canada, the Prostate Forum of Orange County, and TheActiveSurveillor.com.
Please submit questions in advance to moderator Joe Gallo at joeg@ancan.org
View the ASPI session on genetics
Men and their families can learn valuable facts from a cancer genetic test. While the use of genetics testing for cancers is still growing, the existing state of the art for prostate and related cancers is a powerful tool for identifying men and persons at risk. This 60-minute presentation features Robert Finch, MS, a certified genetic counselor, of Myriad Genetics, and medical oncologist Michael Glode, MD.
The video is available at https://aspatients.org/meeting/
When I was working with Mark on a brand identity statement I recommended that education should be at the forefront of what ASPI provides. Very interesting to read this article.
Thanks, Richard. This idea came from our Canadian friends. Hope you can come.
Hope all is well.
Howard